Shanghai Aopeng Medical Technology Co., Ltd.
PrivateLast Round
Series C
Apr 21, 2025
Total Funding Raised
$43.8M
Company Overview
Shanghai Aopeng Medical Technology Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series C round in April 2025.
Shanghai Aopeng Medical Technology Co., Ltd. is a medical robotics company that develops and provides advanced vascular interventional surgery robots with artificial intelligence and 5G technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Aopeng Medical Technology Co., Ltd. Comparables
Compare Shanghai Aopeng Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing WeMed Medical Technology Co., Ltd. | 88% | |
| MicroPort MedBot | 84% | |
| XCath | 80% |
For institutional investors. Book with your work email.
Shanghai Aopeng Medical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 21, 2025 | ||||
| Series B | Aug 16, 2021 | ||||
| Series A | Sep 16, 2020 | ||||
| Pre Seed | Jun 1, 2019 | ||||
| Angel | Jan 1, 2019 |
For institutional investors. Book with your work email.
Shanghai Aopeng Medical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Poly Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2025
Raised $14M in Series C funding.
- Sep 16, 2020
$15M round closed.
For institutional investors. Book with your work email.
Shanghai Aopeng Medical Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai Aopeng Medical Technology Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Aopeng Medical Technology Co., Ltd. a public or private company?
Shanghai Aopeng Medical Technology Co., Ltd. is a private company.
What is the current stock price of Shanghai Aopeng Medical Technology Co., Ltd.?
Shanghai Aopeng Medical Technology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai Aopeng Medical Technology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai Aopeng Medical Technology Co., Ltd. worth (valuation)?
Valuation information for Shanghai Aopeng Medical Technology Co., Ltd. is not publicly available.
Can I buy Shanghai Aopeng Medical Technology Co., Ltd. stock?
Shanghai Aopeng Medical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai Aopeng Medical Technology Co., Ltd.'s last funding round?
Shanghai Aopeng Medical Technology Co., Ltd.'s most recent funding round was Series C on April 21, 2025.
Who are the main investors in Shanghai Aopeng Medical Technology Co., Ltd.?
Key investors in Shanghai Aopeng Medical Technology Co., Ltd. include Poly Capital Management.
Will Shanghai Aopeng Medical Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Aopeng Medical Technology Co., Ltd..
How can I track Shanghai Aopeng Medical Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai Aopeng Medical Technology Co., Ltd.'s shares on secondary markets.